PHARMACYCLICS | abexinostat | Oncology |
ASTRAZENECA | acalabrutinib | Oncology |
ACERTA PHARMA | acalabrutinib | Oncology |
GILEAD | acalisib | Oncology |
ACTINIUM | actinium (225ac) lintuzumab satetraxetan | Oncology |
ASTRAZENECA | adavosertib | Oncology |
ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
PFIZER | agatolimod | Oncology |
SHIONOGI PHARMA | alicdamotide | Oncology |
TAKEDA PHARMACEUTICALS | alisertib | Oncology |
GILEAD | alobresib | Oncology |
FIVE PRIME | alsevalimab | Oncology |
FIVE PRIME | alsevalimab | Oncology |
CHONG KUN DANG | alteminostat | Oncology |
Bristol-Myers Squibb | alvespimycin | Oncology |
Bristol-Myers Squibb | alvespimycin hydrochloride | Oncology |
SANOFI | amcenestrant | Oncology |
SANOFI | amcenestrant | Oncology |
JANSSEN | amivantamab | Oncology |
CELGENE | amrubicin hydrochloride | Oncology |
GILEAD | andecaliximab | Oncology |
JANSSEN | apalutamide | Oncology |
BAYER | aprutumab | Oncology |
BAYER | aprutumab ixadotin | Oncology |
ISOFOL | arfolitixorin | Oncology |
BIOSIGHT | aspacytarabine | Oncology |
GLAXOSMITHKLINE | astuprotimut-r | Oncology |
SHIONOGI PHARMA | asudemotide | Oncology |
GENENTECH | atezolizumab | Oncology |
GENENTECH | autogene cevumeran | Oncology |
GENENTECH | autogene cevumeran | Oncology |
BASILEA PHARMACEUTICALS | avanbulin | Oncology |
BLUEPRINT MEDICINES | avapritinib | Oncology |
ADVAXIS | axalimogene filolisbac | Oncology |
SYNDAX | axatilimab | Oncology |
ABBVIE | azintuxizumab | Oncology |
ABBVIE | azintuxizumab vedotin | Oncology |
IMMUNE DESIGN | baloramotide | Oncology |
GlaxoSmithKline | belantamab | Oncology |
GlaxoSmithKline | belantamab mafodotin | Oncology |
SPECTRUM PHARMACEUTICALS | belinostat | Oncology |
GLAXOSMITHKLINE | belizatinib | Oncology |
HANMI PHARMACEUTICALS | belvarafenib | Oncology |
MERCK & CO. | belzutifan | Oncology |
FIVE PRIME THERAPEUTICS | bemarituzumab | Oncology |
BERGEN BIO | bemcentinib | Oncology |
NEKTAR | bempegaldesleukin | Oncology |
BioInvent International | bersanlimab | Oncology |
VERTEX PHARMACEUTICALS | berzosertib | Oncology |
AMGEN | bevacizumab beta | Oncology |
ASTRAZENECA | bicalutamide | Oncology |
PIQUR | bimiralisib | Oncology |
Inovio | bizalimogene ralaplasmid | Oncology |
MEDIMMUNE | blinatumomab | Oncology |
ONCOMED | brontictuzumab | Oncology |
ABBVIE | budigalimab | Oncology |
FIVE PRIME THERAPEUTICS | cabiralizumab | Oncology |
EXELIXIS | cabozantinib | Oncology |
IMMUNE DESIGN | cadalimogene ixalentivec | Oncology |
ADC THERAPEUTICS | camidanlumab | Oncology |
ADC THERAPEUTICS | camidanlumab tesirine | Oncology |
MONOPAR | camsirubicin | Oncology |
TAKARA BIO | canerpaturev | Oncology |
IMMUNOGEN | cantuzumab ravtansine | Oncology |
ASTRAZENECA | capivasertib | Oncology |
ADVAXIS | capolimogene apralisbac | Oncology |
JOHNSON & JOHNSON | carlumab | Oncology |
TRACON PHARMACEUTICALS | carotuximab | Oncology |
Astex | cedazuridine | Oncology |
ASTRAZENECA | ceralasertib | Oncology |
PORTOLA | cerdulatinib | Oncology |
Janssen | cetrelimab | Oncology |
GENENTECH | cevostamab | Oncology |
JANSSEN | ciltacabtagene autoleucel | Oncology |
PIERIS PHARMACEUTICALS | cinrebafusp alfa | Oncology |
LYCERA | cintirorgon | Oncology |
GENENTECH | cobimetinib | Oncology |
BAYER | copanlisib | Oncology |
CHECKPOINT THERAPEUTICS | cosibelimab | Oncology |
ADURO | damistimagene matitucel | Oncology |
ASTRAZENECA | danvatirsen | Oncology |
JANSSEN | daratumumab | Oncology |
BAYER | darolutamide | Oncology |
DAIICHI-SANKYO | datopotamab | Oncology |
DAIICHI-SANKYO | datopotamab deruxtecan | Oncology |
CERULEAN | davamotecan pegadexamer | Oncology |
ONCOMED | demcizumab | Oncology |
NANOCARRIER | demplatin pegraglumer | Oncology |
SEATTLE GENETICS | denintuzumab mafodotin | Oncology |
ABBVIE | depatuxizumab | Oncology |
ABBVIE | depatuxizumab mafodotin | Oncology |
ARQULE | derazantinib | Oncology |
ARQULE | derazantinib hydrochloride | Oncology |
RAFAEL PHARMACEUTICALS | devimistat | Oncology |
APOTEX | docetaxel | Oncology |
CANTEX PHARMACEUTICALS | dociparstat | Oncology |
NOVARTIS | dovitinib | Oncology |
NOVARTIS | dovitinib lactate | Oncology |
GENENTECH | dulanermin | Oncology |
GENENTECH | duligotuzumab | Oncology |
JANSSEN | duvortuxizumab | Oncology |
ONCOMED | efaprinermin alfa | Oncology |
MEDIMMUNE | efgivanermin alfa | Oncology |
Genexine | efineptakin alfa | Oncology |
ABBVIE | eftozanermin alfa | Oncology |
RADIUS HEALTH | elacestrant | Oncology |
SYNTA PHARMACEUTICALS | elesclomol | Oncology |
ABBVIE | elotuzumab | Oncology |
ONCOTHERAPY SCIENCE | elpamotide | Oncology |
AGIOS | enasidenib | Oncology |
ABBOTT LABORATORIES | enavatuzumab | Oncology |
GLAXOSMITHKLINE | encelimab | Oncology |
ATHENEX | encequidar | Oncology |
SEATTLE GENETICS | enfortumab vedotin | Oncology |
ADURO | enistimagene setitucel | Oncology |
XCOVERY | ensartinib | Oncology |
NEOGENIX ONCOLOGY | ensituximab | Oncology |
GILEAD | entospletinib | Oncology |
IGNYTA | entrectinib | Oncology |
MEDIVATION | enzalutamide | Oncology |
SHIONOGI PHARMA | epertinib | Oncology |
MEDIMMUNE | etaracizumab | Oncology |
Onxeo | etidaligide | Oncology |
OncoMed | etigilimab | Oncology |
NEKTAR | etirinotecan pegol | Oncology |
NEKTAR | etirinotecan pegol tetrahydrochloride | Oncology |
NEKTAR | etirinotecan pegol tetratriflutate | Oncology |
EMD SERONO | evobrutinib | Oncology |
SANOFI | fedratinib | Oncology |
GLAXOSMITHKLINE | feladilimab | Oncology |
STEMLINE THERAPEUTICS | felezonexor | Oncology |
MORPHOSYS | felzartamab | Oncology |
NIPPON KAYAKU | firtecan peglumer | Oncology |
BLUEPRINT MEDICINES | fisogatinib | Oncology |
SIEMENS | flortanidazole (18f) | Oncology |
SIEMENS | flotegatide (18f) | Oncology |
MAST THERAPEUTICS | folitixorin | Oncology |
MAST THERAPEUTICS | folitixorin calcium | Oncology |
OXIGENE | fosbretabulin | Oncology |
OXIGENE | fosbretabulin disodium | Oncology |
OXIGENE | fosbretabulin tromethamine | Oncology |
BIONOVUS LIFE SCIENCES | fosciclopirox | Oncology |
NUCANA | fosgemcitabine palabenamide | Oncology |
NUCANA | fosifloxuridine nafalbenamide | Oncology |
TAIRX | foslinanib | Oncology |
GLYCOTOPE | gatipotuzumab | Oncology |
SANOFI GENZYME | gatralimab | Oncology |
PFIZER | gemtuzumab ozogamicin | Oncology |
ABBVIE | giloralimab | Oncology |
ASTELLAS | gilteritinib | Oncology |
MIRATI THERAPEUTICS | glesatinib | Oncology |
ASTEX | guadecitabine | Oncology |
PHARMACYCLICS | ibrutinib | Oncology |
GILEAD | idelalisib | Oncology |
ABBVIE | ilorasertib | Oncology |
SHIRE PHARMACEUTICALS | imalumab | Oncology |
ROCHE | imgatuzumab | Oncology |
PHOSPLATIN THERAPEUTICS | imifoplatin | Oncology |
TAKEDA PHARMACEUTICALS | indusatumab | Oncology |
TAKEDA PHARMACEUTICALS | indusatumab vedotin | Oncology |
LUNDBECK INC. | ingenol disoxate | Oncology |
BIPAR | iniparib | Oncology |
BIOCANCELL THERAPEUTICS | inodiftagene vixteplasmid | Oncology |
JOHNSON & JOHNSON | intetumumab | Oncology |
ACTINIUM | iodine (131i) apamistamab | Oncology |
ONCOMED | ipafricept | Oncology |
GENENTECH | ipatasertib | Oncology |
SANOFI | isatuximab | Oncology |
AGIOS | ivosidenib | Oncology |
TAKEDA PHARMACEUTICALS | ixazomib | Oncology |
SEATTLE GENETICS | ladiratuzumab | Oncology |
SEATTLE GENETICS | ladiratuzumab vedotin | Oncology |
IMMUNE DESIGN | lapretolimod | Oncology |
IMMUNOGEN | laprituximab | Oncology |
IMMUNOGEN | laprituximab emtansine | Oncology |
DENDREON | lapuleucel-t | Oncology |
VION | laromustine | Oncology |
LOXO ONCOLOGY | larotrectinib | Oncology |
ONCOTHERAPY SCIENCE | latromotide | Oncology |
MOLOGEN | lefitolimod | Oncology |
ADAPTIMMUNE | letetresgene autoleucel | Oncology |
YM BIOSCIENCES | lexibulin | Oncology |
Iovance BIOTHERAPEUTICS | lifileucel | Oncology |
BEIGENE | lifirafenib | Oncology |
ABBVIE | linifanib | Oncology |
OSI PHARMACEUTICALS | linsitinib | Oncology |
BASILEA PHARMACEUTICALS | lisavanbulin | Oncology |
JW THERAPEUTICS | lisocabtagene maraleucel | Oncology |
ADC THERAPEUTICS | loncastuximab | Oncology |
ADC THERAPEUTICS | loncastuximab tesirine | Oncology |
JANSSEN | lorpucitinib | Oncology |
APEIRON | lorukafusp alfa | Oncology |
IMMUNOGEN | lorvotuzumab mertansine | Oncology |
NOVARTIS | lucatumumab | Oncology |
FORTY SEVEN | magrolimab | Oncology |
Inovio | mavilimogene ralaplasmid | Oncology |
X4 | mavorixafor | Oncology |
ONCOPEPTIDES | melphalan flufenamide | Oncology |
SYROS | mevociclib | Oncology |
DAIICHI-SANKYO | milademetan | Oncology |
TAKARA BIO | mipetresgene autoleucel | Oncology |
INSPYR Therapeutics | mipsagargin | Oncology |
ARQULE | miransertib | Oncology |
IMMUNOGEN | mirvetuximab soravtansine | Oncology |
ABBVIE | mirzotamab | Oncology |
ABBVIE | mirzotamab clezutoclax | Oncology |
JANSSEN | mitazalimab | Oncology |
TAKEDA | mivavotinib | Oncology |
TAKEDA | mobocertinib | Oncology |
MIRATI THERAPEUTICS | mocetinostat | Oncology |
MIRATI THERAPEUTICS | mocetinostat dihydrobromide | Oncology |
GLAXOSMITHKLINE | molibresib | Oncology |
EnzyChem | mosedipimod | Oncology |
GENENTECH | mosunetuzumab | Oncology |
BIOLINE | motixafortide | Oncology |
MEDIMMUNE | moxetumomab pasudotox | Oncology |
AMGEN | murizatoclax | Oncology |
GAMAMABS | murlentamab | Oncology |
IMMUNOGEN | naratuximab emtansine | Oncology |
ONCOMED | navicixizumab | Oncology |
ONCOMED | navicixizumab | Oncology |
ABBVIE | navitoclax | Oncology |
CHECKPOINT THERAPEUTICS | olafertinib | Oncology |
ADAPTIMMUNE | olitresgene autoleucel | Oncology |
HANMI PHARMACEUTICALS | olmutinib | Oncology |
CEPHALON | omacetaxine mepesuccinate | Oncology |
GLAXOSMITHKLINE | omipalisib | Oncology |
CELGENE | onatasertib | Oncology |
CELGENE | onatasertib | Oncology |
Janssen | onvatilimab | Oncology |
JANSSEN | opolimogene capmilisbac | Oncology |
AMGEN | oprozomib | Oncology |
TAKEDA PHARMACEUTICALS | orteronel | Oncology |
CELGENE | orvacabtagene autoleucel | Oncology |
GERON | paclitaxel trevatide | Oncology |
CYTOMX THERAPEUTICS | pacmilimab | Oncology |
BEIGENE | pamiparib | Oncology |
DAIICHI-SANKYO | patritumab | Oncology |
JAZZ PHARMACEUTICALS | pegcrisantaspase | Oncology |
AVELAS BIOSCIENCES | pegloprastide | Oncology |
HALOZYME THERAPEUTICS | pegvorhyaluronidase alfa | Oncology |
AEGLEA BIOTHERAPEUTICS | pegzilarginase | Oncology |
ASCENTAGE PHARMA | pelcitoclax | Oncology |
MERCK & CO. | pembrolizumab | Oncology |
Incyte | pemigatinib | Oncology |
JANSSEN | pemlimogene merolisbac | Oncology |
JENNEREX | pexastimogene devacirepvec | Oncology |
DAIICHI-SANKYO | pexidartinib | Oncology |
SANOFI | pilaralisib | Oncology |
GENENTECH | pinatuzumab vedotin | Oncology |
EPIZYME | pinometostat | Oncology |
GENENTECH | polatuzumab vedotin | Oncology |
CELGENE | pomalidomide | Oncology |
ARIAD | ponatinib | Oncology |
ARIAD | ponatinib hydrochloride | Oncology |
HANMI PHARMACEUTICALS | poseltinib | Oncology |
ONCOTHERAPY SCIENCE | pradimotide | Oncology |
BLUEPRINT MEDICINES | pralsetinib | Oncology |
CYTOMX THERAPEUTICS | praluzatamab | Oncology |
CYTOMX THERAPEUTICS | praluzatamab ravtansine | Oncology |
BIO-PATH HOLDINGS | prexigebersen | Oncology |
JOHNSON & JOHNSON | quisinostat | Oncology |
BAYER | radretumab | Oncology |
BAYER | refametinib | Oncology |
4SC | resminostat | Oncology |
ABBVIE | revdofilimab | Oncology |
BETA PHARMA | rezivertinib | Oncology |
ACETYLON | ricolinostat | Oncology |
BELLICUM PHARMACEUTICALS | rimiducid | Oncology |
LSK BIOPHARMA | rivoceranib | Oncology |
ABBVIE | rizankizumab | Oncology |
CLOVIS ONCOLOGY | rociletinib | Oncology |
ABBVIE | rolinsatamab | Oncology |
ABBVIE | rolinsatamab talirine | Oncology |
BAYER | roniciclib | Oncology |
SYNTA PHARMACEUTICALS | rosabulin | Oncology |
ONCOMED | rosmantuzumab | Oncology |
TELIX PHARMACEUTICALS | rosopatamab | Oncology |
TELIX PHARMACEUTICALS | rosopatamab tetraxetan | Oncology |
STEMCENTRX | rovalpituzumab | Oncology |
STEMCENTRX | rovalpituzumab tesirine | Oncology |
LYTIX | ruxotemitide | Oncology |
AbbVie | samrotamab | Oncology |
AbbVie | samrotamab vedotin | Oncology |
TAKEDA PHARMACEUTICALS | sapanisertib | Oncology |
OCTAPHARMA AB | satoreotide | Oncology |
IPSEN BIOPHARM LTD | satoreotide tetraxetan | Oncology |
OCTREOPHARM | satoreotide trizoxetan | Oncology |
ASTRAZENECA | savolitinib | Oncology |
Salarius | seclidemstat | Oncology |
KARYOPHARM | selinexor | Oncology |
LOXO ONCOLOGY | selitrectinib | Oncology |
LOXO ONCOLOGY | selpercatinib | Oncology |
JANSSEN | seltorexant | Oncology |
ASTRAZENECA | selumetinib | Oncology |
ASTRAZENECA | selumetinib sulfate | Oncology |
TAKEDA PHARMACEUTICALS | serabelisib | Oncology |
ABBVIE | serclutamab | Oncology |
ABBVIE | serclutamab talirine | Oncology |
JOHNSON & JOHNSON | serdemetan | Oncology |
SANOFI | seribantumab | Oncology |
INNOCRIN PHARMACEUTICALS | seviteronel | Oncology |
JOHNSON & JOHNSON | siltuximab | Oncology |
GILEAD | simtuzumab | Oncology |
TAKEDA | simurosertib | Oncology |
DENDREON | sipuleucel-t | Oncology |
AMGEN | sitravatinib | Oncology |
Cascadian Therapeutics | sonolisib | Oncology |
BAYER | sorafenib | Oncology |
ONCOTHERAPYSCIENCE | tabituximab | Oncology |
ONCOTHERAPYSCIENCE | tabituximab barzuxetan | Oncology |
MORPHOSYS | tafasitamab | Oncology |
JANSSEN | talacotuzumab | Oncology |
BIOMARIN | talazoparib | Oncology |
JOHNSON & JOHNSON | talmapimod | Oncology |
JANSSEN | talquetamab | Oncology |
ABBVIE | tamrintamab | Oncology |
ABBVIE | tamrintamab pamozirineab | Oncology |
AMGEN | tapotoclax | Oncology |
ONCOMED | tarextumab | Oncology |
THRESHOLD PHARMACEUTICALS | tarloxotinib bromide | Oncology |
DNATRIX THERAPEUTICS | tasadenoturev | Oncology |
GENENTECH | taselisib | Oncology |
OncoSec | tavokinogene telseplasmid | Oncology |
EPIZYME | tazemetostat | Oncology |
TAKARA BIO | tebrocabtagene autoleucel | Oncology |
JANSSEN | teclistamab | Oncology |
BetaCat | tegavivint | Oncology |
CALITHERA | telaglenastat | Oncology |
GLENMARK PHARMACEUTICALS | telazorlimab | Oncology |
ABBVIE | telisotuzumab | Oncology |
ABBVIE | telisotuzumab vedotin | Oncology |
AstraZeneca | telratolimod | Oncology |
ERIMOS PHARMACEUTICALS | terameprocol | Oncology |
ISOTECHNIKA | terameprocol | Oncology |
ABYDERM | tezatabep matraxetan | Oncology |
IDERA PHARMACEUTICALS | tilsotolimod | Oncology |
BERGEN BIO | tilvestamab | Oncology |
GLYCOTOPE | timigutuzumab | Oncology |
MUNDIPHARMA | tinostamustine | Oncology |
GILEAD | tirabrutinib | Oncology |
GENENTECH | tiragolumab | Oncology |
ATHENEX | tirbanibulin | Oncology |
GENEXINE | tirvalimogene teraplasmid | Oncology |
NOVARTIS | tisagenlecleucel | Oncology |
BEIGENE | tislelizumab | Oncology |
DAIICHI-SANKYO | tivantinib | Oncology |
Effector | tomivosertib | Oncology |
GLYCOTOPE | tomuzotuximab | Oncology |
BLAZE BIOSCIENCE | tozuleristide | Oncology |
AMGEN | trebananib | Oncology |
SHIONOGI PHARMA | trempamotide | Oncology |
Cascadian Therapeutics | tucatinib | Oncology |
BIOMED VALLEY | ulixertinib | Oncology |
GLAXOSMITHKLINE | uprosertib | Oncology |
SURFACE ONCOLOGY | urabrelimab | Oncology |
JUNO THERAPEUTICS | vadacabtagene leraleucel | Oncology |
CELGENE | vadacabtagene leraleucel | Oncology |
SEATTLE GENETICS | vadastuximab | Oncology |
SEATTLE GENETICS | vadastuximab talirine | Oncology |
CHONG KUN DANG | valecobulin | Oncology |
ONCOMED | vantictumab | Oncology |
SUNESIS PHARMACEUTICALS | vecabrutinib | Oncology |
INTREXON | veledimex | Oncology |
ABBVIE | veliparib | Oncology |
ABBVIE | venetoclax | Oncology |
MYRIAD | verubulin | Oncology |
GILEAD | vesatolimod | Oncology |
Jounce | vopratelimab | Oncology |
AGIOS | vorasidenib | Oncology |
AGIOS | vorasidenib citrate | Oncology |
TYROGENEX | vorolanib | Oncology |
SEATTLE GENETICS | vorsetuzumab mafodotin | Oncology |
SUNESIS PHARMACEUTICALS | vosaroxin | Oncology |
RADIUS HEALTH | vosilasarm | Oncology |
SANOFI | voxtalisib | Oncology |
MEI PHARMA | zandelisib | Oncology |
ZYMEWORKS | zanidatamab | Oncology |
BEIGENE | zanubrutinib | Oncology |
GLAXOSMITHKLINE | zastumotide | Oncology |
ASTELLAS | zolbetuximab | Oncology |
EFFECTOR | zotatifin | Oncology |